However, none of these two parameters was independently associated with endothelial dysfunction and subclinical atherosclerosis, suggesting that circulating sF11R and ANXA5 might have a minor impact on the pathophysiology of atherosclerosis in diabetic patients. The gene discussed is ANXA5; the disease is endothelial dysfunction.